These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19388481)

  • 1. [Thyroid-stimulating hormone receptor antibodies in the diagnosis of Graves' disease in children].
    Savel'ev LI; Kiiaev AV; Tsvirenko SV; Gerasimova LIu
    Klin Lab Diagn; 2009 Mar; (3):34-6. PubMed ID: 19388481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of TSH receptor antibodies in thyroid diseases.
    Cho BY
    J Korean Med Sci; 2002 Jun; 17(3):293-301. PubMed ID: 12068130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor hyperthyroidism with normal levels of thyroid-stimulating hormone receptor antibodies: a case report.
    Ushakov AV
    J Med Life; 2024 Feb; 17(2):236-238. PubMed ID: 38813368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].
    Eckstein A; Mann K; Kahaly GJ; Grussendorf M; Reiners C; Feldkamp J; Quadbeck B; Bockisch A; Schott M
    Med Klin (Munich); 2009 May; 104(5):343-8. PubMed ID: 19444414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and discrimination of autoimmune Graves' disease and Hashimoto's disease using thyroid-stimulating hormone receptor-containing recombinant proteoliposomes.
    Fukushima H; Matsuo H; Imamura K; Morino K; Okumura K; Tsumoto K; Yoshimura T
    J Biosci Bioeng; 2009 Dec; 108(6):551-6. PubMed ID: 19914592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin receptor autoantibodies in Graves' disease.
    Schott M; Scherbaum WA; Morgenthaler NG
    Trends Endocrinol Metab; 2005 Jul; 16(5):243-8. PubMed ID: 15950483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thyroid autoantibodies].
    Le NH; Ballieux BE; Corssmit EP
    Ned Tijdschr Geneeskd; 2015; 159():A8802. PubMed ID: 26104003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
    Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
    Kasagi K; Hatabu H; Tokuda Y; Iida Y; Endo K; Konishi J
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):357-66. PubMed ID: 2908031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
    Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds.
    Zhyzhneuskaya S; Addison C; Tsatlidis V; Weaver JU; Razvi S
    Thyroid; 2016 Jun; 26(6):765-9. PubMed ID: 27090092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assays for thyroid-stimulating hormone receptor antibodies employing different ligands and ligand partners may have similar sensitivity and specificity but are not interchangeable.
    Pedersen IB; Handberg A; Knudsen N; Heickendorff L; Laurberg P
    Thyroid; 2010 Feb; 20(2):127-33. PubMed ID: 20151820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.
    Nagayama Y; Mizuguchi H; Hayakawa T; Niwa M; McLachlan SM; Rapoport B
    J Immunol; 2003 Apr; 170(7):3522-7. PubMed ID: 12646613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.